A complete application in a minute
Tailored resume and cover letter, ready to send.
Genentech, a Roche company, is seeking a Direct Materials Planner for the Holly Springs, NC site to ensure material availability for continuous production. You will link global supply chain with site manufacturing, manage direct material plans, and coordinate with vendors and the artwork team.
The role requires a Bachelor’s degree with 2+ years in procurement/planning and 5+ years in pharma manufacturing. Onsite with limited travel, relocation not provided.
Pharma Technical Manufacturing (PTM) is responsible for managing all aspects of end-to-end drug substance and drug product manufacturing and supply. From the raw material to the final medicine, we contribute to deliver Roche’s ground-breaking therapies to more than 120 million patients around the world. We make our medicines at 9 sites around the world and coordinate all aspects of production of Roche medicines in all disease areas and dosage forms. To ensure readiness for a step-change in the standard of care that Roche delivers in the area of Cardiovascular, Renal and Metabolism (CVRM), PTM will construct a new manufacturing site in the U.S. in Holly Springs, North Carolina. The new site will focus on large volume low cost Drug Product manufacturing (Component Prep & Compounding, Liquid PFS Filling, Automated Inspection, Autoinjector Assembly, Packaging/Finished Products).
We are seeking a highly skilled Direct Materials Planner to join our Materials Management team as an individual contributor. In this role, you will be directly responsible for ensuring material availability to support continuous production demand. Serving as a crucial link between global supply chain, procurement, and site manufacturing operations, you will actively manage inventory levels, mitigate material risks, and serve as the site artwork change coordinator to align packaging materials with updated specifications.
You have a bachelor's degree and two years of relevant supply chain purchasing, procurement, or planning experience.
The expected salary range for this position based on the primary location for this position of Holly Springs, North Carolina $77,400 - $143,800. Actual pay will be determined based on experience, level, qualifications, geographic location, and other job-related factors permitted by law. A discretionary annual bonus may be available based on individual and Company performance.
Genentech is an equal opportunity employer. It is our policy and practice to employ, promote, and otherwise treat any and all employees and applicants on the basis of merit, qualifications, and competence. The company's policy prohibits unlawful discrimination, including but not limited to, discrimination on the basis of Protected Veteran status, individuals with disabilities status, and consistent with all federal, state, or local laws. If you have a disability and need an accommodation in relation to the online application process, please contact us by completing this form Accommodations for Applicants.
Genentech is an equal opportunity employer. It is our policy and practice to employ, promote, and otherwise treat any and all employees and applicants on the basis of merit, qualifications, and competence. The company's policy prohibits unlawful discrimination, including but not limited to, discrimination on the basis of Protected Veteran status, individuals with disabilities status, and consistent with all federal, state, or local laws. If you have a disability and need an accommodation in relation to the online application process, please contact us by completing this form Accommodations for Applicants.
Genentech, a member of the Roche group and founder of the biotechnology industry, is dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. To solve the world's most complex health challenges, we ask bigger questions that challenge our industry and the boundaries of science to transform society. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. The next step is yours.